An Efficacy and Safety Study of JNJ-38518168 in Adult Participants With Rheumatoid Arthritis

NCT00941707 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

86

Enrollment

INDUSTRY

Sponsor class

Stopped Due to a single, unexpected serious event, the trial was stopped.

Conditions

Rheumatoid Arthritis

Interventions

DRUG: JNJ 38518168
DRUG: Placebo

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.